azathioprine has been researched along with guanethidine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Vetten, KB | 1 |
| Tuerk, M | 1 |
| Johnson, EM; Manning, PT; Russell, JH | 1 |
1 review(s) available for azathioprine and guanethidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for azathioprine and guanethidine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Immunosuppressive therapy and anaesthesia.
Topics: Adult; Animals; Antilymphocyte Serum; Azathioprine; Body Weight; Drug Synergism; Guanethidine; Humans; Kidney Transplantation; Liver Transplantation; Male; Methylcellulose; Mice; Nephrectomy; Neuromuscular Nondepolarizing Agents; Potassium; Toxiferine; Transplantation, Homologous; Tubocurarine | 1973 |
Skin grafting in systemic lupus erythematosus patients who are on steroids.
Topics: Adult; Azathioprine; Chlorothiazide; Debridement; Female; Guanethidine; Humans; Leg Injuries; Lupus Erythematosus, Systemic; Middle Aged; Neomycin; Polymyxins; Prednisone; Skin Transplantation; Transplantation, Autologous | 1972 |
Immunosuppressive agents prevent guanethidine-induced destruction of rat sympathetic neurons.
Topics: Animals; Azathioprine; Cyclophosphamide; Dexamethasone; Ganglia, Sympathetic; Guanethidine; Hydroxydopamines; Immune Sera; Immunosuppressive Agents; Nerve Growth Factors; Neurons; Oxidopamine; Rats; Sympathectomy, Chemical; Tyrosine 3-Monooxygenase | 1982 |